Found: 6
Select item for more details and to access through your institution.
Creatine kinase elevation in chronic hepatitis B patients with telbivudine therapy: influence of telbivudine plasma concentration and single nucleotide polymorphisms of TK2, RRM2B, and NME4.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 7, p. 1029, doi. 10.1007/s00228-024-03674-w
- By:
- Publication type:
- Article
Cumulative incidence and risk factors of creatine kinase elevation associated with telbivudine.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 2, p. 235, doi. 10.1007/s00228-015-1978-9
- By:
- Publication type:
- Article
Comprehensive Analysis of Common Serum Liver Enzymes as Prospective Predictors of Hepatocellular Carcinoma in HBV Patients.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0047687
- By:
- Publication type:
- Article
Determination of telbivudine in the plasma of chronic hepatitis B patients in long‐term treatment by high‐performance liquid chromatographic–tandem mass spectrometry.
- Published in:
- Biomedical Chromatography, 2018, v. 32, n. 4, p. 1, doi. 10.1002/bmc.4140
- By:
- Publication type:
- Article
Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora.
- Published in:
- Frontiers in Microbiology, 2023, p. 1, doi. 10.3389/fmicb.2023.1232180
- By:
- Publication type:
- Article
Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora.
- Published in:
- Frontiers in Microbiology, 2023, p. 1, doi. 10.3389/fmicb.2023.1232180
- By:
- Publication type:
- Article